Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study

Figure 1 Scatter plots of serum prothrombin time, albumin, total bilirubin, ascites volume and model for end-stage liver disease score before and after autologous bone marrow infusion in control and intervention groups. A: Scatter plot of serum prothrombin time levels before and after autologous bone marrow infusion (ABMI) in both groups; B: Scatter plot of serum albumin levels before and after ABMI in both groups; C: Scatter plot of serum total bilirubin levels before and after ABMI in both groups; D: Scatter plot of ascites volume before and after ABMI in both groups; E: Scatter plot of model for end-stage liver disease score before and after ABMI in both groups. Compared with before ABMI, ^aP < 0.01. PT: Prothrombin time; TB: Total bilirubin; MELD: Model for end-stage liver disease; ALB: Albumin.

Figure 2 Scatter plots of white blood cell, platelet and hemoglobin levels before and after autologous bone marrow infusion in control and intervention groups. A: Scatter plot of white blood cell count before and after autologous bone marrow infusion (ABMI) in both groups; B: Scatter plot of platelet count before and after ABMI in both groups; C: Scatter plot of hemoglobin level before and after ABMI in both groups. Compared with before ABMI, ^aP < 0.01; compared with control group, ^bP < 0.05, ^cP < 0.01. WBC: White blood cell; PLT: Platelet; Hgb: Hemoglobin.

Figure 3 Scatter plot of CD4⁺ T and CD8⁺ T counts in control and intervention groups before and after autologous bone marrow infusion. A: Scatter plot of CD4⁺ T cell count in both groups before and after autologous bone marrow infusion (ABMI); B: Scatter plot of CD8⁺ T cell count in both groups before and after ABMI. Compared with before ABMI, ^aP < 0.01.